A complex of proteins involved in cellular trafficking, called the BBSome, plays a role in regulating the transport of dopamine,…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A buildup of fat-like lipid molecules may help to promote the inability of dopaminergic neurons, the nerve cells that are…
About 15% of Parkinson’s disease cases are tied to genetic variants and nearly all are associated with the LRRK2…
Cognitive function in adults with Parkinson’s disease either remains stable or progressively declines over time, according to a four-year…
A protein called STAT3 protected nerve cells from degeneration and improved behavioral and motor outcomes in a rat model of…
A study reports that the proteins NAP1 and SINTBAD play a role in regulating mitophagy, a process wherein damaged mitochondria…
A new visual diagnostic technique called Cap-QuIC has the potential to advance the early detection of neurodegenerative diseases, such as…
Depletion of the neurotransmitter dopamine, which occurs in people with Parkinson’s disease, disrupts the balance of motor pathways in…
Clumps of RNA-binding proteins have been discovered in the nucleus of nerve cells derived from people with Parkinson’s disease,…
Six months of once-daily buntanetap halted cognitive decline among people in the early stages of Parkinson’s disease, and…